Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de Burgos (17)

2024

  1. Efficacy and safety and efficacy of bempedoic acid in acute coronary syndrome. Design of the clinical trial ES-BempeDACS

    Revista Espanola de Cardiologia

2023

  1. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  2. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Percutaneous Closure of Mitral Paravalvular Leak: Long-Term Results in a Single-Center Experience

    Journal of Clinical Medicine, Vol. 11, Núm. 16

  2. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

    Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633

  2. Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart

    Clinical and Experimental Medicine, Vol. 21, Núm. 2, pp. 249-268

  3. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19

    Age and ageing, Vol. 50, Núm. 2, pp. 326-334

  4. MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 142-152

  5. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data

    Medicina Clinica, Vol. 157, Núm. 7, pp. 318-324

2020

  1. 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry

    IJC Heart and Vasculature, Vol. 31

  2. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration

    International Journal of Cardiology, Vol. 307, pp. 17-23

  3. Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)

    American Journal of Cardiology, Vol. 127, pp. 1-8

  4. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group

    Circulation: Cardiovascular Imaging, Vol. 13, Núm. 4, pp. E010105

2018

  1. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 19, Núm. 4, pp. 296-303

  2. Spanish Catheter Ablation Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017)

    Revista Espanola de Cardiologia, Vol. 71, Núm. 11, pp. 941-951

2016

  1. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

    Journal of the American College of Cardiology, Vol. 68, Núm. 22, pp. 2440-2451